Researchers are to trial Botox to treat hay fever after early tests showed promising results. Under the trial, a Botox gel will be applied to the nose to hopefully give hay fever sufferers relief from sneezing, itchy eyes and runny noses for up to three months. It is hoped that the botulinum toxin will affect the nerves in the nose and potentially block some of the chemicals released by the nerve endings which play a large role in causing hay fever symptoms. Australian scientists have re-engineered the Botox molecule to be able to penetrate through the skin but also through the lining of the nose in a bid to treat the allergy. Philip Bardin, a professor at the Monash Medical Centre, said that Botox was already widely used in medicine to reduce spasms in muscles following strokes and in treating cerebral palsy. "This is very new way to use an old medication," the Daily Mail quoted him as saying. Botox, which makes muscles relax, is a purified form of a nerve poison and is produced by bacteria that cause a disease which paralyses muscles. 70 people will be recruited for the new study following a preliminary trial that suggested the drug provided relief. ( ANI
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor